Highlights and Quick Summary
- Long Term Tax Liability (Deferred) for the quarter ending June 30, 2022 was $8.22 Million (a -17.44% decrease compared to previous quarter)
- Year-over-year quarterly Long Term Tax Liability (Deferred) decreased by -36.63%
- Annual Long Term Tax Liability (Deferred) for 2021 was $10.2 Million (a -14.61% decrease from previous year)
- Annual Long Term Tax Liability (Deferred) for 2020 was $11.9 Million (a 174.65% increase from previous year)
- Annual Long Term Tax Liability (Deferred) for 2019 was $4.33 Million (a 22.28% increase from previous year)
Visit stockrow.com/ANIK
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long Term Tax Liability (Deferred) of Anika Therapeutics Inc.
Most recent Long Term Tax Liability (Deferred)of ANIK including historical data for past 10 years.Interactive Chart of Long Term Tax Liability (Deferred) of Anika Therapeutics Inc.
Anika Therapeutics Inc. Long Term Tax Liability (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $8.22 | $9.96 | – | – | – |
| 2021 | $10.16 | $12.97 | $13.1 | $10.74 | $10.16 |
| 2020 | $11.9 | $12.58 | $14.86 | $16.03 | $11.9 |
| 2019 | $4.33 | $4.73 | $3.68 | $3.39 | $4.33 |
| 2018 | $3.54 | $4.12 | $5.4 | $5.3 | $3.54 |
| 2017 | $5.39 | $7.59 | $7.0 | $6.72 | $5.39 |
| 2016 | $6.55 | $6.32 | $6.57 | $7.42 | $6.55 |
| 2015 | $6.78 | $8.97 | $8.63 | $8.8 | $6.78 |
| 2014 | $7.74 | $8.35 | $8.28 | $8.62 | $7.74 |
| 2013 | $7.94 | $8.32 | $6.73 | $6.78 | $7.94 |
| 2012 | $7.0 | $6.44 | $6.49 | $7.03 | $7.0 |
| 2011 | $7.38 | $6.86 | – | – | $7.38 |
Business Profile of Anika Therapeutics Inc.
Sector: Healthcare
Industry: Medical Devices